Echo Therapeutics, Inc.
DelistedCIK 1031927fmd_0JT4E5WDE0CCHGSVCG8RVPMHANManufacturing · Electromedical & Electrotherapeutic ApparatusTemplate: Standard
Coverage: Jan 01, 2010 to Sep 30, 2016, 26 periods
Latest annual · FY2015
Millions- Total revenues
- 0
- Operating income
- (18)
- Net income
- (22)
Latest quarter · Q3 FY2016
Millions- Total revenues
- 0
- Operating income
- (2)
- Net income
- 1
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2012 to FY2015
- n/m
- Revenue, 5 yearsFY2010 to FY2015
- n/m
- Net income, 5 yearsFY2010 to FY2015
- n/m
Echo Therapeutics, Inc. financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2015 | FY2014 | Change | Source |
|---|---|---|---|---|
| Revenue | $0 | $57,321 | -100% | 10-K 2016-03-30 · proof |
| Operating income | -$17.5 million | -$12.3 million | 10-K 2016-03-30 · proof | |
| Net income | -$22.2 million | -$15 million | 10-K 2016-03-30 · proof | |
| Cash from operating activities | -$5.1 million | -$10.7 million | 10-K 2016-03-30 · proof | |
| Total assets | $805,090 | $12.6 million | -93.6% | 10-K 2016-03-30 · proof |
| Total liabilities | $3.3 million | $3.1 million | +8.4% | 10-K 2016-03-30 · proof |
| Cash and cash equivalents | $56,210 | $1.3 million | -95.6% | 10-K 2016-03-30 · proof |
- What was Echo Therapeutics, Inc.'s revenue in fiscal 2015?
- Echo Therapeutics, Inc. reported revenue of $0 for fiscal 2015 (the year ended Dec 31, 2015), against $57,321 the year before (-100%). Source: the 10-K filed with the SEC on Mar 30, 2016. SEC
- What was Echo Therapeutics, Inc.'s operating income in fiscal 2015?
- Echo Therapeutics, Inc. reported operating income of -$17.5 million for fiscal 2015 (the year ended Dec 31, 2015), against -$12.3 million the year before. Source: the 10-K filed with the SEC on Mar 30, 2016. SEC
- What was Echo Therapeutics, Inc.'s net income in fiscal 2015?
- Echo Therapeutics, Inc. reported net income of -$22.2 million for fiscal 2015 (the year ended Dec 31, 2015), against -$15 million the year before. Source: the 10-K filed with the SEC on Mar 30, 2016. SEC
- What was Echo Therapeutics, Inc.'s cash from operating activities in fiscal 2015?
- Echo Therapeutics, Inc. reported cash from operating activities of -$5.1 million for fiscal 2015 (the year ended Dec 31, 2015), against -$10.7 million the year before. Source: the 10-K filed with the SEC on Mar 30, 2016. SEC
- What are Echo Therapeutics, Inc.'s total assets?
- As of Dec 31, 2015, Echo Therapeutics, Inc. reported total assets of $805,090, against $12.6 million a year earlier (-93.6%). Source: the 10-K filed with the SEC on Mar 30, 2016. SEC
- What are Echo Therapeutics, Inc.'s total liabilities?
- As of Dec 31, 2015, Echo Therapeutics, Inc. reported total liabilities of $3.3 million, against $3.1 million a year earlier (+8.4%). Source: the 10-K filed with the SEC on Mar 30, 2016. SEC
- What are Echo Therapeutics, Inc.'s cash and cash equivalents?
- As of Dec 31, 2015, Echo Therapeutics, Inc. reported cash and cash equivalents of $56,210, against $1.3 million a year earlier (-95.6%). Source: the 10-K filed with the SEC on Mar 30, 2016. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1031927&period_type=annual&limit=5"Information only, not investment advice.